| Literature DB >> 15577756 |
Antonella Tosti1, Massimiliano Pazzaglia, Stylianos Voudouris, Giovanni Tosti.
Abstract
The phenyl-substituted analog of prostaglandin F 2alpha , latanoprost (Xalatan; Pfizer, Inc, New York, NY) is an intraocular pressure (IOP)-lowering drug for use in patients with glaucoma and ocular hypertension. Latanoprost has been shown to stimulate eyelash hypertrichosis and has recently been proposed as a possible treatment for alopecia areata involving the eyelashes. We report a case of hypertrichosis of the eyelashes caused by the prostamide bimatoprost (Lumigan; Allergan, Inc, Irvine, Calif), a new IOP-lowering drug.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15577756 DOI： 10.1016/j.jaad.2004.05.002
Source DB: PubMed Journal: J Am Acad Dermatol ISSN： 0190-9622 Impact factor: 11.527